Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2010
06/03/2010WO2009157684A3 Gsl8 and use thereof
06/03/2010WO2009126688A8 Novel compositions and methods for the treatment of immune related diseases
06/03/2010WO2009100040A8 Cell lines expressing gaba receptor and methods using them
06/03/2010WO2008132743A3 Production of high mannose proteins in plant culture
06/03/2010WO2003006486A3 Bcr-abl oligomerization domain polypeptides and uses therefor
06/03/2010US20100138963 DNA Molecules from Maize and Methods of Use Thereof
06/03/2010US20100138961 Axmi-010, a delta-endotoxin gene and methods for its use
06/03/2010US20100138957 Hybrid peptides having antimicrobial activity and methods of making and using hybrid peptides
06/03/2010US20100138956 Nitrogen transport metabolism
06/03/2010US20100138942 Use of the augmenter of liver regeneration protein as an apoptosis regulator
06/03/2010US20100138935 Detection of cellular stress
06/03/2010US20100137641 Gene involved in quorum-sensing system of acetic acid bacterium, acetic acid bacterium bred by modification of the gene and method for production of vinegar by using the acetic acid bacterium
06/03/2010US20100137583 Peptidomimetic protease inhibitors
06/03/2010US20100137566 Compounds and Methods Used to Treat Infectious Diseases
06/03/2010US20100137565 Genetically modified yeasts for the production of homogenous glycoproteins
06/03/2010US20100137563 Cysteine Protease Autoprocessing of Fusion Proteins
06/03/2010US20100137562 Mavs in the prevention and treatment of viral disease
06/03/2010US20100137561 Process for preparing therapeutic peptide
06/03/2010US20100137560 Oligopeptides and their use in cosmetics
06/03/2010US20100137559 Process for production of cyclic peptides
06/03/2010US20100137558 Mono modified exendin with polyethylene glycol or its derivatives and uses thereof
06/03/2010US20100137557 Use of one or more metal carriers to selectively kill mammalian cells
06/03/2010US20100137511 Polymer factor ix moiety conjugates
06/03/2010US20100137220 Blood sugar-modulating polypeptides
06/03/2010US20100137218 Expression System of NELL Peptide
06/03/2010US20100137216 Axmi-027, axmi-036 and axmi-038, a family of delta-endotoxin genes and methods for their use
06/03/2010US20100137214 Chimeric hirudin proteins
06/03/2010US20100137210 Gastrointestinal proliferative foctor and uses thereof
06/03/2010US20100137209 Modified plasminogen activator inhibitor type-1 and methods based thereon
06/03/2010US20100137207 G protein coupled receptor agonists and antagonists and methods of activating and inhibiting g protein coupled receptors using the same
06/03/2010US20100137205 Use of FGF-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation
06/03/2010US20100137201 Medicaments
06/03/2010US20100137196 Histone deacetylases, and uses related thereto
06/03/2010US20100137191 Protective agents for transplanted organs
06/03/2010US20100137189 Modified globin proteins with altered electron transport pathway
06/03/2010US20100137158 GFABS: GFP-based biosensors possessing the binding properties of antibodies
06/03/2010US20100136710 RNA processing protein complexes and uses thereof
06/03/2010US20100136684 Natural IgM Antibodies
06/03/2010US20100136663 preparation of an artificial transcription factor comprising zinc finger protein and transcription factor of prokaryote, and a use thereof
06/03/2010US20100136628 competing with natural OX40L for blocking OX40R-mediated cell signaling in the prophylaxis and/or treatment of diseases related to activated T cells
06/03/2010US20100136625 Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
06/03/2010US20100136624 Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
06/03/2010US20100136623 Mutations in ion channels
06/03/2010US20100136620 Soluble, stable form of hdm2, crystalline forms thereof and methods of use thereof
06/03/2010US20100136595 Hydrocarbon-forming oxidative decarbonylase enzyme, hydrocarbons produced thereby, and method of use
06/03/2010US20100136590 Method of Determining NT-proBNP
06/03/2010US20100136581 Diagnosis and treatment of malignant neoplasms
06/03/2010US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation
06/03/2010US20100136558 Canine cd20 gene
06/03/2010US20100136535 Means and methods for detecting protein-peptide interactions
06/03/2010US20100136528 Fiat nucleic acids and proteins and uses thereof
06/03/2010US20100136527 Dominant B Cell Epitopes and Methods of Making and Using Thereof
06/03/2010US20100136524 Target protein and target gene in drug designing and screening method
06/03/2010US20100136522 Endogenous retroviruses up-regulated in prostate cancer
06/03/2010US20100136519 Determination of a specific immunoglobulin using multiple antigens
06/03/2010US20100136211 IFBM's to Promote the Specific Attachment of Target Analytes to the Surface of Orthopedic Implants
06/03/2010US20100136203 Fermented whey prepration and method for producing the same
06/03/2010US20100136100 Removal promoters and inhibitor for apoptosis cells in vivo
06/03/2010US20100136091 Methods, systems, and compositions for extracellular matrix production
06/03/2010US20100136070 Methods, devices, and compositions for dermal filling
06/03/2010US20100136062 Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy
06/03/2010US20100136057 Virulence of streptococci
06/03/2010US20100136054 Flavivirus ns1 subunit vaccine
06/03/2010US20100136052 Replication deficient influenza virus for the expression of heterologous sequences
06/03/2010US20100136045 Novel shigella protein antigens and methods
06/03/2010US20100136039 Borrelia antigens
06/03/2010US20100136038 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines
06/03/2010US20100136036 Unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions
06/03/2010US20100136023 Therapeutic agents
06/03/2010US20100136020 Uses of il-174 antagonists for inhibiting a th2 immune response
06/03/2010US20100136017 Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer
06/03/2010US20100136016 Heat shock proteins from mycobacterium leprae and uses thereof
06/03/2010US20100136014 GIPs, a Family of Polypeptides with Transcription Factor Activity that Interact with Goodpasture Antigen Binding Protein
06/03/2010US20100136011 Antibodies that bind to obm
06/03/2010US20100136010 Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
06/03/2010US20100136007 Csf1r extracellular domain fusion molecules and treatments using same
06/03/2010US20100136003 Uses of mammalian cytokine; related reagents
06/03/2010US20100135985 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them an uses thereof
06/03/2010US20100135959 Human Interferon Molecules and Their Uses
06/03/2010US20100135957 Chimeric Heteromultimer Adhesins
06/03/2010US20100135955 HUMAN M2e PEPTIDE IMMUNOGENS
06/03/2010CA2750421A1 Surface active proteins as excipients in solid pharmaceutical formulations
06/03/2010CA2746984A1 Method for preparing of human recombinant insulin
06/03/2010CA2744675A1 Identification of porcine reproductive and respiratory syndrome virus
06/03/2010CA2744555A1 Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2
06/03/2010CA2744379A1 Expression cassettes for seed-specific expression in plants
06/03/2010CA2743850A1 Variants of activin iib receptor polypeptides and uses thereof
06/03/2010CA2742529A1 Detecting antigen responsive cells in a sample
06/03/2010CA2742241A1 Binding proteins inhibiting the vegf-a receptor interaction
06/03/2010CA2742144A1 Hosts and fermentation processes for cellulase production
06/03/2010CA2741887A1 A method of protecting against heart failure
06/03/2010CA2740793A1 Method for the treatment of hemophilia
06/03/2010CA2740147A1 Sulfonylurea-responsive repressor proteins
06/03/2010CA2711462A1 Novel antibiotic peptide derived from ribosomal protein l 1 of helicobacter pylori and use thereof
06/02/2010EP2192188A1 Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products
06/02/2010EP2192184A1 Detection of bacterium belonging to genus campylobacter which targets cytolethal distending toxin
06/02/2010EP2192179A1 Cdh3 peptide and medicinal agent comprising the same
06/02/2010EP2192172A1 System for expression of genes in plants
06/02/2010EP2192132A2 Anti-IL-20, anti-IL22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation
06/02/2010EP2192131A1 Immunoglobulins devoid of light chains
1 ... 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 ... 2916